Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
eli lilly
fda
life sciences
national blog main
national top stories
2
×
abbvie
abeona therapeutics
achaogen
affordable care act
alkermes
allergan
alnylam pharmaceuticals
alzheimer's
amgen
astrazeneca
biosimilar
biotech
boulder/denver blog main
boulder/denver top stories
brexanolone
buprenorphine
cariprazine
celiac disease
chris collins
coherus biosciences
cydan development
deals
detroit blog main
detroit top stories
egfr
europe
europe blog main
europe top stories
felipe jain
foamix pharmaceuticals
gene therapy
gop
What
panel
2
×
alkermes
alzheimer’s
antipsychotic
benefits
bio
caveats
commonly
congress
democrats
designed
divided
drug
effect
elections
fallout
favor
fda
gain
losses
medicine
midterm
offer
plenty
political
postpartum
prescribed
psyche
roundup
search
stake
terms
took
treatment
vote
week’s
weighs
weight
wins
won
Language
unset
Current search:
panel
×
" national top stories "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
